Scientific Report on consumer health-based guidance values for trifluoroacetic acid.

Authors

EFSA (European Food Safety Authority), Adeline Cavelier, Tamara Coja, Andrea Gall, Antonio Hernández-Jerez, Christiane Vleminckx, Elodie Bergsma, Marco Binaglia, Federica Crivellente, Mathilde Colas, Anna Lanzoni, Jochem Louisse, Rafaela Rodrigues De Jesus, Annetta Grillo, Iris Mangas, Juan Manuel Parra Morte

Published in

EFSA journal. European Food Safety Authority. Volume 24. Issue 7. Pages e10227. Epub Jul 22, 2026.

Abstract

The European Commission asked EFSA to provide a scientific report according to Article 31 of Regulation (EC) No 178/2002, in conjunction with Regulation (EC) No 1107/2009, to revise consumer health-based guidance values, i.e. acceptable daily intake (ADI) and acute reference dose (ARfD), for trifluoroacetic acid (TFA). EFSA launched a targeted call for data from 6 August to 7 October 2024 and established an EFSA Working Group. Based on the weight of evidence, the WG concluded that TFA and its salt, TFA Na, are unlikely to be genotoxic. The WG established an ADI of 0.014 mg/kg body weight (bw) per day (expressed as trifluoroacetic acid) derived from the parental benchmark dose lower confidence limit (BMDL₂₀) of 8.6 mg/kg bw per day. This value is based on changes in thyroid hormones, specifically decreased thyroxine (T4) levels, observed in the extended one-generation reproductive toxicity study in rats. A standard uncertainty factor of 100 was applied to account for inter- and intra-species differences. An additional factor of 5 was applied to address remaining uncertainties, namely the absence of a long-term toxicity/carcinogenicity study and the potential for developmental immunotoxicity, given the lack of functional immunotoxicity testing for TFA during the developmental phase. In addition, an ARfD of 0.07 mg/kg bw (expressed as trifluoroacetic acid) was derived based on the same BMDL₂₀ of 8.6 mg/kg bw per day, by applying a standard uncertainty factor of 100.

PMID:
42488728
Bibliographic data and abstract were imported from PubMed on 23 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.